Amélie Montel-Hagen Selected Research

Chimeric Antigen Receptors

1/2023	Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells.
11/2021	Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amélie Montel-Hagen Research Topics

Disease

3	Neoplasms (Cancer) 01/2023 - 01/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021
1	Anemia 12/2008
1	T-Cell Leukemia (Leukemia, T Cell) 07/2008

Drug/Important Bio-Agent (IBA)

2	Chimeric Antigen ReceptorsIBA 01/2023 - 11/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021
1	AntigensIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 12/2008
1	Glycoproteins (Glycoprotein)IBA 07/2008
1	Bos taurus BLVR proteinIBA 07/2008

Therapy/Procedure

2	Immunotherapy 01/2023 - 11/2021
1	Therapeutics 11/2021